Evaluation of the Safety of External Application of Herbal Oil (“Gidan”) on Horses’ Limbs Savariego, G., Tatz, J.A., Segev, G., Kelmer, G

Total Page:16

File Type:pdf, Size:1020Kb

Evaluation of the Safety of External Application of Herbal Oil (“Gidan”) on Horses’ Limbs Savariego, G., Tatz, J.A., Segev, G., Kelmer, G Evaluation of the Safety of External Application of Herbal Oil (“Gidan”) on Horses’ Limbs Savariego, G., Tatz, J.A., Segev, G., Kelmer, G. Koret School of Veterinary Medicine, The Robert H. Smith Faculty of Agriculture, Food and Environment, The Hebrew University of Jerusalem, P.O.B. 12, Rehovot 76100, Israel. * Corresponding Author: Dr. Gal Kelmer, DVM., Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, Israel. ABSTRACT Tendons and ligaments injuries are highly common in the equine population and they tend to carry a high recurrence rate and prolonged healing period. The treatment and prevention of tendon injuries is complex and the combination of complementary and alternative methods into current regimes may be beneficial. However, the literature regarding the safety and efficacy of such treatments is scarce. “Gidan” is an herbal liniment, designed according to traditional Chinese methods, for the relief of muscle and tendon related pain. This study aimed to evaluate the safety of external application of “Gidan” on distal limbs of horses and lay the foundation for future studies evaluating the efficacy of “Gidan” and similar materials. “Gidan” was applied twice daily on two distal limbs of 10 horses for a 7 day period. The two remaining limbs served as controls and were treated with a carrier liniment without the “Gidan” herbal extracts. Two limbs of each horse (“Gidan” and control) were bandaged. Allocation to treatments was random. Adverse skin reactions were assessed, ranked and photographed during the trial period and at 5 days following last application. Nearly half of the limbs tested exhibited mild adverse skin reactions, most of them delayed and were only visible days after application was ceased. Analysis shows that bandaging was clearly the main risk factor for developing such reactions. It was concluded that “Gidan” was not the cause of the dermatological reactions. The external topical use of “Gidan” herbal liniment on horses’ distal limbs appeared to be safe on non- bandaged limbs. The use of bandaging requires further evaluation. Keywords: Gidan; Herbal; Safety; Chinese Medicine; Equine; Tendonitis. INTRODUCTION successfully (2). The anatomical architecture of tendons Lameness and other orthopedic problems were ranked in and ligaments is designed to allow tendons to passively a comprehensive survey conducted in the USA as the most transfer force generated by muscle to bony attachments prevalent health issue affecting horses (1). Furthermore, on the opposite side of a joint, or joints and in so doing lameness was ranked by horse owners, riders and veterinar- provide movement. The biomechanically most significant ians as the most concerning problem regarding the horse’s tendons and ligaments are located on the palmar/plantar health as it leads to a substantial loss of working days and aspect of the equine distal limb. At that location they receive may even lead to euthanasia (1). Injuries attributed to significant weight-bearing loads and, are responsible for the tendons and ligaments are perceived as being potentially majority of the movements of the horse (3). The unique threatening to an equine athlete’s career as their initial structural arrangement within tendons and ligaments al- subtle clinical sign often tend to delay recognition at lows the horse to exercise at high speeds while minimizing which point they become severe and difficult to manage energy expenditure (3). 26 Savariego, G. Israel Journal of Veterinary Medicine Vol. 70 (3) September 2015 Research Articles The tendons, type 1 collagen fibers, have a crimp pattern the herbal essence to directly reach the underlying tissues that contributes to its elasticity and enables storing energy in (10). Compared with oral route of administration avoiding an effective manner. These tendons are subjected to repeated the initial hepatic screening and allows the medication to motion and degeneration over time and thus they are prone exert its effect continuously as absorption advances (10). to both acute and chronic injuries (4). Due to high collagen Allergies are a potential adverse effect of virtually any content and low cell numbers, tendons and ligaments have a herbal or synthetic medication applied topically or systemi- slow metabolic rate of activity and it may take 8–12 months cally (11). Numerous human reports of allergic and other to regain adequate tensile strength after significant damage dermatological reaction to herbal medicines are known to (5). Recurrence of tendon injury after return to full work occur, tending to be mild to moderate and transient in nature is rather frequent, depending on the severity of the injury, (11). Though herbal medication is generally perceived as safe, rehabilitation program, tendon involved, forelimb versus especially when applied topically, a cutaneous adverse effect is hind-limb and the therapies applied (5). always a possibility and topical application of herbal remedies The treatment and prevention of tendon and ligament is not without risk (11). injuries is complex and usually requires a combination of TCM is considered one of the most ancient healing arts methods and disciplines in order to achieve the optimal known to man, with documentation of practice of over 3000 results. Currently used modalities include, among others, years. The Traditional Chinese Veterinary Medicine (TCVM) conservative methods such as anti-inflammatory medication, has developed in close conjunction with the TCM. Though ice and bandaging incorporated into a long resting period relatively new to western culture, the implementation of simi- (5). Recent and advanced methods aim to reduce healing lar methods in animal medicine, has been known and well period and re-injury occurrence. One potentially useful documented for thousands of years (12). The incorporation of modality is the extracorporeal shockwave therapy, due to its TCVM methods to the western veterinary medicine practice analgesic properties and it possible enhanced tendon healing is continuously growing due to increased interest both by by stimulating vascular in-growth (6). Recently regenera- pet owners and practitioners, seeking complementary and tive medicine has been gaining increasing popularity; these alternative treatment modalities and options (13). therapies include autogenous stem cell implantation, bone According to the TCM, herbs used for medicinal pur- marrow or adipose tissue derived and platelets rich plasma poses hold a variety of characteristics, representing different (PRP) (7). All these regenerative modalities are aimed at traits that are harnessed in order to apply proper medication. promoting cell proliferation, differentiation and improving Formulating herbal remedies requires proper integration of the quality and the speed of healing. These methods seem those characteristics in order to achieve harmony and regain to carry an enormous potential but at this point lack solid balance (13). scientific support (5). “Gidan” liniment has been used by athletes, physical Currently, the use of complementary and alternative therapist and orthopedists for the relief of muscle and ten- medicine is slowly establishing its status among other don related pain post exercise for almost a decade, without therapeutic options as a valid and beneficial modality avail- any known adverse effects (14). “Gidan” is composed of an able for the equine practitioner (8). One major mode is the assembly of herbs extracts and essential oils based on their use of herbs and herbal extracts from traditional Chinese therapeutic and medicinal virtues as attributed by TCM. medicine (TCM) via topical application. This mode of ap- The basis of the liniment is Olive oil (olea europaea, 68%) plication has major advantages as it increases the assurance solidified with bee wax (18%) and it contains the following that the herb interacts with the target tissue and reduces extracts: MO YAO (Myrrh, commiphora myrrha), XIANG concern of systemic effects. Topical application also allows RU) Olibanum, Boswellia carteri), HONG HUA (Safflower, easy monitoring and observation regarding treatment effec- Carthamus tinctorius) and SAN QI (Notoginseng, Panax tiveness and whether adverse reactions, e.g. allergy, irritation, pseudoginseng) that according to TCM invigorates blood to or progression of the disease, are on going (9). TCM prac- relieve pain, reduce swelling, and promotes tissue regenera- titioners usually rely on the use of topical herbal pastes for tion (15). The liniment also contains the following essential metabolic enhancements of tissue repairs. This route allows oils (<0.5% each): Eucalyptus )Eucalyptus globules(, Lavender Israel Journal of Veterinary Medicine Vol. 70 (3) September 2015 Safety Study of Gidan Treatment 27 Research Articles (Lavandula officinalis), Lemon (Citrus limonum), Rosmary and were treated with the solidified olive oil, and afterwards (Rosmarinus officinalis), Mint (Mentha piperita), Nutmeg one of the two limbs was also bandaged in the same manner (Myristica fragrans) and Vitamin E (Tocopherol). as the treated one. The materials were administered twice The rising interest in combining herbal use with routine daily (q12h), manually, using new examination gloves for veterinary medicine is in contrast to the lack of studies evalu- each material for each horse. ating the efficacy and safety. This study aims to evaluate the safety of external application of “Gidan” on distal limbs of Designation of groups horses. Ideally, this safety study
Recommended publications
  • Camphor Revisited: Focus on Toxicity
    Camphor Revisited: Focus on Toxicity Committee on Drugs This commentary updates a previous AAP state- TABLE. List of Camphor-Containing Products ment developed by the Committee on Drugs con- Product % of Camphor cerning camphor.1 The original commentary re- Absorbine Arthritic Pain Lotion 10 flected the level of concern among pediatric Act-On Rub Lotion 1.5 practitioners and poison centers about the toxicity of Anabaim Lotion 3 camphor. Since the original statement, the Food and Aveeno Anti-Itch Conc. Lotion 0.3 t Drug Administration (FDA) has recognized camphor Avalgesic Banaig Muscle Pain Reliever 2 as a safe and effective topical antitussive, analgesic, Bangesic t anesthetic, and antipruritic agent.2 Following the ap- Ben Gay Children’s Vaporizing Rub 5 proval process in 1983, the FDA required that the Betuline Lotion t concentration of camphor in products not exceed Campho-phemque First Aid Gel 10.8 Campho-phenique Uquid 10.85 11%.2 Fligher concentrations were not more effective Campho-phemque Powder 4.375 and could cause more serious adverse reactions if Counterpain Rub t accidentally ingested. Most reported camphor-re- Deep Down Rub 0.5 lated fatalities involved agents containing a concen- Dencorub Cream Dermal Rub t tration greater than 11%. Dermolin Liniment t Ingestion of potentially toxic substances by chil- Emul-O-Balm 1.1 dren is related to the availabffity of a product in their Heet Lotion 3 3.6 environment. Camphor remains widely available Heat Spray Minit-Rub 3.5 (Table). The toxicity of camphor when inappropri- Mollifene Ear Drops t ately used is well documented.6 Ingestion is the Musterole Regular 4 most common route of potentially toxic exposure, Panalgesic 3 with rapid onset of toxic effects.
    [Show full text]
  • Absorbine Veterinary Liniment for Horses
    Doc# 03.287 Ver. 11 SAFETY DATA SHEET ABSORBINE® VETERINARY LINIMENT SECTION 1 - PRODUCT AND COMPANY IDENTIFICATION 1.1 Trade Name (as labeled): Absorbine® Veterinary Liniment Synonyms: N/A CAS No: Mixture 1.2 Product Use: Soothes sore muscles and stiff joints 1.3 Company Name: W.F. Young Company Address: 302 Benton Dr Company Address Cont: East Longmeadow, MA 01028 Business Phone: ( 413) 526-9999 Website: www.wfyoung.com 1.4 Emergency Telephone Number: (413) 526-9999 Date of Current Revision: January 17, 2017 Date of Last Revision: August 7, 2015 SECTION 2 - HAZARD IDENTIFICATION EMERGENCY OVERVIEW: This product is a green thin liquid with an acetone odor. Health Hazards: May cause skin, eye, and respiratory system irritation. Flammabilit Hazards: This product is a flammable liquid with a flash point over 20°F (-6. 7°C). Reactivit Hazards: None. Environmental Hazards: The environmental effectsof this product have not been investigated, however release may cause long term adverse environmental effects. US DOT Symbols: EU and GHS Symbols: Signal Word: Danger! 2.1 CLASSIFICATION OF SUBSTANCE OR MIXTURE IN ACCORDANCE WITH 29 CFR 1200 (OSHA HCSl AND THE EUROPEAN UNION DIRECTIVES: This product does meet the definition of a hazardous substance or preparation as defined by 29 CFR 1910. 1200 or the European Union Council Directives 67 /548/EEC, 1999/45/EC, 1272/2008/EC and subsequent Directives. EU HAZARD CLASSIFICATIONOF INGREDIENTS PER DIRECTIVE 1272/2008/EC: IndexNumber: EC# 201-939-0 This substance is not classified in the AnnexVI of Directive 67/548/EEC EC# 200-662-2 This substance is classified in the AnnexVI of Directive 67/548/EEC Index# 606-001-00-8 Substances not listed either individually or in group entries must be self classified.
    [Show full text]
  • Veterinary Dairy Spray Liniment by Dan Leiterman
    1-888-376-6777 www.crystalcreeknatural.com December 2011 Introducing - Veterinary Dairy Spray Liniment By Dan Leiterman Crystal Creek is pleased to announce the addition of the new Veterinary Dairy Spray Liniment Features: Veterinary Dairy Spray Liniment • Available In A 24 oz. Spray Bottle Or A One Gallon (128 oz.) Refill Jug (VDSL) to our family of liniments (Veterinary Dairy Liniment and • A High Performance – Strong Relief Formula: Lini-Rub). Veterinary Dairy Spray Liniment provides the same ‘Contrast Therapy’ Warming and Cooling excellent performance as the original Analgesic Pain Relief rub-on Veterinary Dairy Liniment, only now with the convenience of a Anti-Inflammatory spray-on application. Anti-Microbial Skin Support – an aloe vera based formula Veterinary Dairy Spray Liniment is a powerful analgesic that combines • New Color For Lingering Identification Of Sprayed Animals the proven benefits of both warming and cooling ‘contrast therapy’ for • Meets National Organic Program Standards – challenged muscle tissue and edema Consider For Organic Use relief. The deep penetrating warmth soothes and supports proper • Economical To Use: circulation, while the lingering Retail Price coolness helps to reduce edema and inflammation of muscle tissue. 24 oz. Spray Bottle $29.95 / bottle If you prefer a spray-on liniment, Case Price (6 bottles/case) try Veterinary Dairy Spray Liniment and see the difference – it is stronger $28.95 / bottle and is better priced than the One Gallon Jug competition. If you prefer rub-on $134.00 / gallon liniments, try the Veterinary Dairy Case Price (4 gallons/case) Liniment (a white cream based $128.00 / gallon liniment) or the Crystal Creek Lini- Rub (an oil based liniment) and experience their excellent performance.
    [Show full text]
  • TOXICOLOGY and EXPOSURE GUIDELINES ______(For Assistance, Please Contact EHS at (402) 472-4925, Or Visit Our Web Site At
    (Revised 1/03) TOXICOLOGY AND EXPOSURE GUIDELINES ______________________________________________________________________ (For assistance, please contact EHS at (402) 472-4925, or visit our web site at http://ehs.unl.edu/) "All substances are poisons; there is none which is not a poison. The right dose differentiates a poison and a remedy." This early observation concerning the toxicity of chemicals was made by Paracelsus (1493- 1541). The classic connotation of toxicology was "the science of poisons." Since that time, the science has expanded to encompass several disciplines. Toxicology is the study of the interaction between chemical agents and biological systems. While the subject of toxicology is quite complex, it is necessary to understand the basic concepts in order to make logical decisions concerning the protection of personnel from toxic injuries. Toxicity can be defined as the relative ability of a substance to cause adverse effects in living organisms. This "relative ability is dependent upon several conditions. As Paracelsus suggests, the quantity or the dose of the substance determines whether the effects of the chemical are toxic, nontoxic or beneficial. In addition to dose, other factors may also influence the toxicity of the compound such as the route of entry, duration and frequency of exposure, variations between different species (interspecies) and variations among members of the same species (intraspecies). To apply these principles to hazardous materials response, the routes by which chemicals enter the human body will be considered first. Knowledge of these routes will support the selection of personal protective equipment and the development of safety plans. The second section deals with dose-response relationships.
    [Show full text]
  • Safety Data Sheet
    First issue: September 17, 2009 Revision date: October 27, 2014 SDS No. 007.636 Version: 5 SAFETY DATA SHEET In accordance with OSHA’s Hazard Communication Standard 29 CFR §1910.1200 SECTION 1: IDENTIFICATION OF THE SUBSTANCE/MIXTURE AND OF THE COMPANY/UNDERTAKING 1.1. Product identifier: Absorbine® Veterinary Liniment Gel 1.2. Relevant identified uses of the substance or mixture and uses advised against Topical Analgesic 1.3. Details of the supplier of the safety data sheet Manufacturer/Supplier: W. F. Young, Inc. 302 Benton Drive East Longmeadow, MA 01028 Telephone number for information: 413 526 9999 E-mail: [email protected] 1.4. Emergency telephone number 413 526 9999 SECTION 2: HAZARDS IDENTIFICATION 2.1. Classification of the mixture F, Xn, Xi R10, 22, 43 2.2. Label elements Flammable Keep out of the reach of children Harmful if swallowed May product an allergic reaction 2.3. Other hazards Inhalation of vapors can cause anesthetic effect. Page 1 of 8 First issue: September 17, 2009 Revision date: October 27, 2014 SDS No. 007.636 Version: 5 SECTION 3: COMPOSITION/INFORMATION ON INGREDIENTS 3.2. Mixtures Hazardous ingredients information Component CAS Nr. EINECS / Amount DSD DSD ELINCS (%) Hazard R-Phrases Symbol Ethanola,denatured 64-17-5 200-578-6 40 - 70 F R11 Menthol 89-78-1 201-939-0 4 Choroxylenol 88-04-0 201-793-8 0.5 Xi R43 Spearmint Oil 8008-79-5 Not classified 0.5-1.0 Xi R43 Propylene Glycola 57-55-6 200-338-0 1 - 5 Other Components: Remaining components of this alcoholic mixture are proprietary, non-hazardous and/or are present at concentrations below reportable limits.
    [Show full text]
  • Biopharmaceutical Properties of Patches Relevant for Transdermal Drug Absorption – Confounding Factors and In‐Vitro Testing
    Biopharmaceutical Properties of Patches 16.06.2015 Relevant for Transdermal Drug Absorption Biopharmaceutical Properties of Patches Relevant for Transdermal Drug Absorption – Confounding Factors and In‐Vitro Testing Johannes Bartholomäus Pharmakreativ Consulting, Aachen Skin as Barrier to Transdermal Absorption And that’s from what Mother Nature did not design all the difficulties in transdermal drug skin as an absorption site. delivery arise. It‘s much more the opposite! Stratum corneum as lipophilic barrier June 16, 2015 J. Bartholomäus: Biopharmaceutical Properties of Patches 2 © Johannes Bartholomäus 1 Biopharmaceutical Properties of Patches 16.06.2015 Relevant for Transdermal Drug Absorption Definition TDDS by Guidelines . Transdermal drug delivery systems . Transdermal patch:** Flexible single‐ (TDDS):* A TDDS or transdermal dose preparation intended to be patch is a flexible pharmaceutical applied to the unbroken skin to preparation of varying size containing obtain a systemic delivery over an one or more active substance(s) to be extended period of time. applied on the intact skin for systemic . Transdermal patches consist of a availability. backing sheet supporting a reservoir . There are two main types of or a matrix containing the active transdermal patch systems substance(s) and on the top a depending on how the drug pressure‐sensitive adhesive, which substance is dispersed in other patch assures the adhesion of the components: preparation to the skin. – Matrix systems with drug release based on . The backing sheet is impermeable to the diffusion of drug substance. the active substance(s) and normally – Reservoir systems containing a specific liquid drug compartment and release is impermeable to water. controlled by a membrane.
    [Show full text]
  • Pulmonary Delivery of Biological Drugs
    pharmaceutics Review Pulmonary Delivery of Biological Drugs Wanling Liang 1,*, Harry W. Pan 1 , Driton Vllasaliu 2 and Jenny K. W. Lam 1 1 Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong, China; [email protected] (H.W.P.); [email protected] (J.K.W.L.) 2 School of Cancer and Pharmaceutical Sciences, King’s College London, 150 Stamford Street, London SE1 9NH, UK; [email protected] * Correspondence: [email protected]; Tel.: +852-3917-9024 Received: 15 September 2020; Accepted: 20 October 2020; Published: 26 October 2020 Abstract: In the last decade, biological drugs have rapidly proliferated and have now become an important therapeutic modality. This is because of their high potency, high specificity and desirable safety profile. The majority of biological drugs are peptide- and protein-based therapeutics with poor oral bioavailability. They are normally administered by parenteral injection (with a very few exceptions). Pulmonary delivery is an attractive non-invasive alternative route of administration for local and systemic delivery of biologics with immense potential to treat various diseases, including diabetes, cystic fibrosis, respiratory viral infection and asthma, etc. The massive surface area and extensive vascularisation in the lungs enable rapid absorption and fast onset of action. Despite the benefits of pulmonary delivery, development of inhalable biological drug is a challenging task. There are various anatomical, physiological and immunological barriers that affect the therapeutic efficacy of inhaled formulations. This review assesses the characteristics of biological drugs and the barriers to pulmonary drug delivery.
    [Show full text]
  • We Have Some Trouble with Special Characters and Displaying Monographs. 22.09.2018 ATC Code: D04AB01 Classification
    We have some trouble with special characters and displaying monographs. 22.09.2018 ATC code: D04AB01 Classification: PNP - Probably not porphyrinogenic Substance: Lidocaine Rationale for risk classification: Lidocaine is metabolized by CYP1A2, with only a minor contribution from CYP 3A4. Lidocaine is not listed as an inducer or as a mechanism-based inhibitor of CYP enzymes, nor is there any evidence of lidocaine capacity for Cyp-inhibition in clinical use. Lidocaine is reported as used uneventfully by 68 patients, and thus strong clinical evidence points to lidocaine as probably not porphyrinogenic. The systemic availability of lidocaine after restricted dermal use is usually low. Chemical description: Lidocaine hydrochloride is an amide derivative of diethyl amino acetic acid. Lidocaine has a lipophilic aromatic ring attached to a hydrophilic amino group by an amide linkage. Therapeutic characteristics: Lidocaine is a local anesthetic. In dermatological preparations lidocaine is used for the symptomatic relief of pain, itching or irritation of the skin or mucous membranes. It can be administered in topical formulations like ointment, gel or liniment for conditions like superficial skin wounds, insect bites, burns, herpes genitalis, and anal lesions or before various medical procedures. Extent of hepatic exposure: The plasma concentration of lidocaine is dependent on dose, administration method and vascularity of the site of administration. Whether the site of application has a traumatised or intact surface will also affect the absorption and systemic availability of the drug. Lidocaine is readily absorbed from mucous membranes and through damaged skin The hepatic exposure of lidocaine after restricted dermal use is probably not significant.. Systemic plasma concentrations after repeted anorectal administration of 5 % lidocaine ointment was found to be below uM (Zimmermann 2007).
    [Show full text]
  • Dosage Form FDA Data Element Number
    Home Drugs Development & Approval Process (Drugs) Forms & Submission Requirements Electronic Submissions to CDER Data Standards Manual (monographs) Drugs Dosage Form FDA Data Element Number. None. CDER Data Element Number. C-DRG-00201 Data Element Name. Dosage Form. Data Element OID: 2.16.840.1.113883.3.26.1.1.2 Data Element NCI Concept ID: C42636 Version Number. 008 Description. This standard provides for all drug dosage forms. The granularity of data often requires that more specific dosage form terms be stored in automated databases than are represented in publications. These dosage form terms are available not only for use in databases that track approved drug products, but also for drug products such as: those that have not been approved, investigational drug products, homeopathic drug products, biologic products, veterinary drug products, and bulk drug products. A ‘use restrictions’ column is being added to help identify where a particular dosage form set or subset should be used (a=CDER Databases, b=NDC Directory, c=Orange Book). The definitions for Lotion, Cream, Ointment, and Paste were revised on June 21, 2006 to include information that would assist the user in differentiating between these dosage forms. These changes were the result of discussions during an FDA Advisory Committee with an open public forum, scientific studies that were published in refereed pharmaceutical journals, and internal discussions by Agency personnel, including the usual adherence to the criteria that are specified in MaPP 7600.4. A 1999 Food and Drug Administration Draft Guidance for Industry states: "A dosage form is the way of identifying the drug in its physical form.
    [Show full text]
  • Hinkson Creek Comprehensive Chemical Analysis Proposal
    UNITED STATES GOVERNMENT memorandum DATE: August 29, 2019 REPLY TO ATTN OF: David Alvarez, USGS, 573-441-2970, [email protected] SUBJECT: Cost estimate for the analysis of water and sediment samples from Hinkson Creek TO: Lynne Hooper, Boone County Resource Management, [email protected] Investigation of continued causes of impairment in Hinkson Creek is of interest to the Hinkson Creek Science Team. Some work has been done looking at basic water quality parameters, but little data exists looking at organic and inorganic contaminants which may be related to increased urbanization in the watershed. The Environmental Chemistry Branch was asked to develop a sampling plan which includes potential indicator chemicals that may indicate an increased contaminant loading into the Creek. Below is an estimate for the chemical analysis of water and sediment samples from Hinkson Creek. The costs below represent totals for the sampling at 5 sites each during an upcoming Fall and Spring season. Options for both water and sediment analyzes are included. Proposed chemicals to be investigated include: a suite of metals typical of urban environments, current use pesticides (CUP) related to agriculture, wastewater indicators (WI), polycyclic aromatic hydrocarbons (PAHs), organochlorine pesticides, polychlorinated biphenyls (total PCBs), and polybrominated diphenyl ether (PBDE) flame retardants. A tentative list of analytes is provided as an attachment to this memo. In addition to the specific chemical analyses, a screen for total estrogenicity of chemicals will be run using the in vitro yeast estrogen screen (YES). The YES assay is a cell-based assay where estrogens or estrogen-mimicking chemicals bind to an estrogen receptor which can be measured.
    [Show full text]
  • Pharmaceutical Compounding and Dispensing Sample Chapter
    Copyright Pharmaceutical Press www.pharmpress.com 6 Solutions Introduction and overview 101 Gargles and mouthwashes 105 General principles of solution preparation 103 Enemas and douches 105 Solubility 103 External solutions 105 Stability 103 Lotions 105 General method 103 Liniments 105 Oral solutions 104 Applications 105 Elixirs 104 Collodions 106 Linctuses 105 Worked examples 106 Syrups 105 Summary of essential principles relating to solutions 112 Mixtures 105 Packaging 112 Draughts 105 Discard dates 112 Spirits 105 Labelling 113 Paediatric drops 105 Introduction and overview Essentially a solution is a homogeneous liquid preparation that contains one or more dissolved med- Solutions are one of the oldest dosage forms used in the icaments. Since, by definition, active ingredients are treatment of patients and afford rapid and high dissolved within the vehicle, uniform doses by volume absorption of soluble medicinal products. Therefore, may be obtained without any need to shake the for- the compounding of solutions retains an important mulation. This is an advantage over some other for- place in therapeutics today. Owing to the simplicity mulation types (e.g. suspensions, see Chapter 7). and hence the speed of preparation of an ad hoc for- In general, water is chosen as the vehicle in which mulation, they are of particular use for individuals medicaments are dissolved, as it is non-toxic, non- who have difficulty in swallowing solid dosage forms irritant, tasteless, relatively cheap, and many drugs (for example paediatric, geriatric, intensive care and are water soluble. Problems may be encountered psychiatric patients), where compliance needs to be where active drugs are not particularly water soluble checked on administration (for example in prisons or or suffer from hydrolysis in aqueous solution.
    [Show full text]
  • Guide for the Selection of Personal Protective Equipment for Emergency First Responders
    U.S. Department of Justice Office of Justice Programs National Institute of Justice National Institute of Justice Law Enforcement and Corrections Standards and Testing Program Guide for the Selection of Personal Protective Equipment for Emergency First Responders NIJ Guide 102–00 Volume I November 2002 U.S. Department of Justice Office of Justice Programs 810 Seventh Street N.W. Washington, DC 20531 John Ashcroft Attorney General Deborah J. Daniels Assistant Attorney General Sarah V. Hart Director, National Institute of Justice For grant and funding information, contact: Department of Justice Response Center 800–421–6770 Office of Justice Programs National Institute of Justice World Wide Web Site World Wide Web Site http://www.ojp.usdoj.gov http://www.ojp.usdoj.gov/nij U.S. Department of Justice Office of Justice Programs National Institute of Justice Guide for the Selection of Personal Protective Equipment for Emergency First Responders NIJ Guide 102-00, Volume I Dr. Alim A. Fatah1 John A. Barrett2 Richard D. Arcilesi, Jr.2 Charlotte H. Lattin2 Charles G. Janney2 Edward A. Blackman2 Coordination by: Office of Law Enforcement Standards National Institute of Standards and Technology Gaithersburg, MD 20899–8102 Prepared for: National Institute of Justice Office of Science and Technology Washington, DC 20531 November 2002 This document was prepared under CBIAC contract number SPO-900-94-D-0002 and Interagency Agreement M92361 between NIST and the Department of Defense Technical Information Center (DTIC). NCJ 191518 1National Institute of Standards and Technology, Office of Law Enforcement Standards. 2Battelle Memorial Institute. National Institute of Justice Sarah V. Hart Director This guide was prepared for the National Institute of Justice, U.S.
    [Show full text]